Comparative Effectiveness of Early-line Nab-paclitaxel vs. Paclitaxel in Patients with Metastatic Breast Cancer: a US Community-based Real-world Analysis

Reshma Mahtani

Comparative Effectiveness of Early-line Nab-paclitaxel vs. Paclitaxel in Patients with Metastatic Breast Cancer: a US Community-based Real-world Analysis

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Abstract

Reshma L Mahtani 1 , Monika Parisi 2 , Stefan Glück 3 , Quanhong Ni 2 , Siyeon Park 4 , Corey Pelletier 2 , Claudio Faria 2 , Fadi Braiteh 5 6

Original language	American English
Journal	Cancer management and research
Volume	10
State	Published - 2018

Disciplines

Medicine and Health Sciences

Cite this

@article{a03ade25bc95455aaae8b841165bc671,

title = "Comparative Effectiveness of Early-line Nab-paclitaxel vs. Paclitaxel in Patients with Metastatic Breast Cancer: a US Community-based Real-world Analysis",

abstract = " Reshma L Mahtani 1 , Monika Parisi 2 , Stefan Gl{\"u}ck 3 , Quanhong Ni 2 , Siyeon Park 4 , Corey Pelletier 2 , Claudio Faria 2 , Fadi Braiteh 5 6 ",

author = "Reshma Mahtani",

note = "doi: 10.2147/CMAR.S150960. 1 Division of Hematology/Oncology, University of Miami, Miami, FL. 2 Health Economics and Outcomes Research, Celgene Corporation, Summit, NJ. 3 Global Medical Affairs, Celgene Corporation, Summit, NJ. 4 School of Pharmacy, The Ohio State University, Columbus, OH. 5 Department of Hematology/Oncology, University of Nevada School of Medicine, Las Vegas, NV.",

year = "2018",

language = "American English",

volume = "10",

journal = "Cancer management and research",

}

TY - JOUR

T1 - Comparative Effectiveness of Early-line Nab-paclitaxel vs. Paclitaxel in Patients with Metastatic Breast Cancer: a US Community-based Real-world Analysis

AU - Mahtani, Reshma

N1 - doi: 10.2147/CMAR.S150960. 1 Division of Hematology/Oncology, University of Miami, Miami, FL. 2 Health Economics and Outcomes Research, Celgene Corporation, Summit, NJ. 3 Global Medical Affairs, Celgene Corporation, Summit, NJ. 4 School of Pharmacy, The Ohio State University, Columbus, OH. 5 Department of Hematology/Oncology, University of Nevada School of Medicine, Las Vegas, NV.

PY - 2018

Y1 - 2018

N2 - Reshma L Mahtani 1 , Monika Parisi 2 , Stefan Glück 3 , Quanhong Ni 2 , Siyeon Park 4 , Corey Pelletier 2 , Claudio Faria 2 , Fadi Braiteh 5 6

AB - Reshma L Mahtani 1 , Monika Parisi 2 , Stefan Glück 3 , Quanhong Ni 2 , Siyeon Park 4 , Corey Pelletier 2 , Claudio Faria 2 , Fadi Braiteh 5 6

UR - https://pubmed.ncbi.nlm.nih.gov/29445301/

M3 - Article

VL - 10

JO - Cancer management and research

JF - Cancer management and research

ER -

Comparative Effectiveness of Early-line Nab-paclitaxel vs. Paclitaxel in Patients with Metastatic Breast Cancer: a US Community-based Real-world Analysis

Abstract

Disciplines

Other files and links

Cite this